Will stem cells in cord blood, amniotic fluid, bone marrow and peripheral blood soon be unnecessary in transplantation?

Journal and index pages often block iframe embedding. This reader keeps the evidence details in Orthonotes and leaves the source page one click away.

Abstract

[Indexed for MEDLINE] 19. Clin Orthop Relat Res. 2005 Jun;(435):22-30. doi: 10.1097/01.blo.0000165849.32661.5e. Safety and FDA regulations for musculoskeletal allografts: perspective of an orthopaedic surgeon. Joyce MJ(1). Author information: (1)Department of Orthopaedic Surgery, Cleveland Clinic Foundation, 9500 Euclid Avenue/A41, Cleveland, OH 44195, USA. joycem@ccf.org The Musculoskeletal Transplant Foundation Symposium held in September 2003, in Edinburgh, Scotland provided the opportunity for an orthopaedic surgeon experienced in tissue banking and musculoskeletal allograft transplantation to summarize to orthopaedic colleagues the past and current efforts made by the Food and Drug Administration to ensure the safety of allograft tissues, aspects of tissue banking, concerns of allograft safety and future Food and Drug Administration proposals. The review allows an orthopaedic surgeon an understanding of allograft safety issues and provides information for better informed consent to be obtained by the orthopaedic surgeon from the recipient patient. DOI: 10.1097/01.blo.0000165849.32661.5e